BNTX Earnings & Financial Statements
BioNTech SE
$90.20
+$1.54(+1.74%)
49
Overall
60
Value
40
Tech
47
Quality
Market Cap
$22.27B
Volume
1.06M
52W Range
$79.52 - $124.00
Target Price
$121.94
BNTX earnings and financial statements: BioNTech SE's income statement, balance sheet and cash flow statement, annual and quarterly.
BNTX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.87B | $2.75B | - | $17.31B | $18.98B |
| Cost of revenue | $641.80M | $541.30M | - | $3.00B | $2.91B |
| Operating income | -$316.60M | -$502.80M | - | $12.30B | $14.92B |
| EBITDA | -$598.20M | -$352.30M | - | $12.43B | $15.00B |
| Net income | -$1.14B | -$690.10M | - | $9.43B | $10.29B |
| EPS (diluted) | - | $-2.77 | $3.83 | $37.77 | $39.63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTX | $90.20 | +1.7% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |